THEODORE NYQUIST: Open Payments
NPI 1609972926 · MCMINNVILLE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 27 payments from 14 companies in 2025. Trend: 2023 $1,062 · 2024 $1,201 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| GlaxoSmithKline, LLC. | 4 | $87 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 2 | $50 |
| Exact Sciences Corporation | 3 | $46 |
| Madrigal Pharmaceuticals | 1 | $39 |
| Lilly USA, LLC | 2 | $35 |
| Viatris Specialty LLC | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, SHINGRIX, REZDIFFRA, KISUNLA, ELIQUIS.
Industry payments across OR — which companies pay providers there.
